Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. (not Streamex Corp.) on October 15, 2019. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The report discloses a material definitive agreement regarding the expansion of the company's operational footprint.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a corporate event rather than periodic financial performance data.
Material Changes and Corporate Actions
- New Facility: On October 15, 2019, the Company announced the opening of a new technology development office.
- Location: The office is located at Discovery Square, a 16-block sub-district in Rochester, Minnesota.
- Strategic Partnership: Discovery Square was built in collaboration with the Mayo Clinic.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future earnings, or specific risk factors beyond the standard disclosure of the new agreement. The primary outlook is operational, signaling a commitment to technology development in a strategic location.
Investor Verification Checklist
- Verify the strategic rationale for locating the new office at Discovery Square and its expected impact on R&D costs.
- Review the full text of the press release (Exhibit 99.1) for details on lease terms or capital expenditures not included in this summary.
- Confirm the company's current cash position in the most recent 10-Q or 10-K to assess the ability to fund this expansion.
- Note the discrepancy between the requested company name (Streamex Corp.) and the actual registrant (BioSig Technologies, Inc.).